MDT

95.62

+0.66%↑

VEEV

283

-3.27%↓

A

141.9

+0.66%↑

HQY

91.19

+0.35%↑

TLRY

1.55

+1.31%↑

MDT

95.62

+0.66%↑

VEEV

283

-3.27%↓

A

141.9

+0.66%↑

HQY

91.19

+0.35%↑

TLRY

1.55

+1.31%↑

MDT

95.62

+0.66%↑

VEEV

283

-3.27%↓

A

141.9

+0.66%↑

HQY

91.19

+0.35%↑

TLRY

1.55

+1.31%↑

MDT

95.62

+0.66%↑

VEEV

283

-3.27%↓

A

141.9

+0.66%↑

HQY

91.19

+0.35%↑

TLRY

1.55

+1.31%↑

MDT

95.62

+0.66%↑

VEEV

283

-3.27%↓

A

141.9

+0.66%↑

HQY

91.19

+0.35%↑

TLRY

1.55

+1.31%↑

Search

Assertio Holdings Inc

Cerrado

0.79 -2.47

Resumen

Variación precio

24h

Actual

Mínimo

0.79

Máximo

0.81

Métricas clave

By Trading Economics

Ingresos

-2.8M

-16M

Ventas

2.7M

29M

Margen de beneficio

-55.958

Empleados

58

EBITDA

6.9M

-6.4M

Recomendaciones

By TipRanks

Recomendaciones

Compra Fuerte

Estimación a 12 meses

+204.88% upside

Dividendos

By Dow Jones

Próximas Ganancias

10 nov 2025

Estadísticas de Mercado

By TradingEconomics

Capitalización de Mercado

12M

81M

Apertura anterior

3.26

Cierre anterior

0.79

Puntuación técnica

By Trading Central

Confianza

Strong Bullish Evidence

Assertio Holdings Inc Gráfico

El rendimiento pasado no es un indicador fiable de resultados futuros.

Noticias Relacionadas

16 oct 2025, 21:10 UTC

Principales Movimientos del Mercado

Kezar Life Sciences Shares Surge After Break with FDA, Restructuring Plan

16 oct 2025, 19:03 UTC

Adquisiciones, fusiones, absorciones

Canada Signals Limited Concern Over U.S. Government Stakes in Canadian Miners -- 2nd Update

16 oct 2025, 17:58 UTC

Adquisiciones, fusiones, absorciones

Canada Signals Limited Concern Over U.S. Government Stakes in Canadian Miners -- Update

16 oct 2025, 17:12 UTC

Ganancias

Ray-Ban Maker EssilorLuxottica's Revenue Surges to Quarterly Record -- Update

16 oct 2025, 17:12 UTC

Adquisiciones, fusiones, absorciones

Canada Signals Limited Concern Over US Government Stakes in Canadian Miners

16 oct 2025, 16:59 UTC

Adquisiciones, fusiones, absorciones

Airbus's Takeover of Spirit AeroSystems Plants Gets French Antitrust Clearance

16 oct 2025, 23:44 UTC

Charlas de Mercado

Gold Climbs Amid Safe-Haven Demand -- Market Talk

16 oct 2025, 23:42 UTC

Charlas de Mercado

Nikkei May Fall, Tracking Wall Street's Declines -- Market Talk

16 oct 2025, 23:42 UTC

Charlas de Mercado

Global Equities Roundup: Market Talk

16 oct 2025, 22:15 UTC

Ganancias

China Tower: Results Supported by Higher Contributions From Energy, Smart Tower Business >0788.HK

16 oct 2025, 22:15 UTC

Ganancias

China Tower 9-Mos Rev CNY74.32B Vs. CNY72.45B >0788.HK

16 oct 2025, 22:15 UTC

Ganancias

China Tower 9-Mos Net CNY8.71B Vs. Net CNY8.15B >0788.HK

16 oct 2025, 22:02 UTC

Charlas de Mercado

Global Equities Roundup: Market Talk

16 oct 2025, 22:02 UTC

Charlas de Mercado

Santos Drifts Into 'Oversold Territory' -- Market Talk

16 oct 2025, 20:50 UTC

Charlas de Mercado

Financial Services Roundup: Market Talk

16 oct 2025, 20:50 UTC

Charlas de Mercado
Ganancias

Health Care Roundup: Market Talk

16 oct 2025, 20:23 UTC

Charlas de Mercado

Global Forex and Fixed Income Roundup: Market Talk

16 oct 2025, 20:23 UTC

Charlas de Mercado

Recession Risks to Push Canada Toward October Rate Cut -- Market Talk

16 oct 2025, 20:20 UTC

Ganancias

These Stocks Moved the Most Today: TSMC, Salesforce, HPE, F5, United Airlines, Travelers, J.B. Hunt, Praxis Precision, and More -- Barrons.com

16 oct 2025, 20:08 UTC

Adquisiciones, fusiones, absorciones

Jack in the Box to Sell Del Taco With Big Markdown. The Stock Plunged. -- Barrons.com

16 oct 2025, 19:37 UTC

Adquisiciones, fusiones, absorciones

Crypto Industry Dives Deeper Into Prediction Markets as Kraken Buys Exchange -- Barrons.com

16 oct 2025, 19:26 UTC

Ganancias

Oracle Weighs In on Cloud Margins. The Stock Is Rising. -- Barrons.com

16 oct 2025, 19:24 UTC

Charlas de Mercado

U.S. Natural Gas Falls on Mild Weather, Ample Storage -- Market Talk

16 oct 2025, 19:23 UTC

Charlas de Mercado

Oil Falls As Oversupply Concerns Outweigh India News -- Market Talk

16 oct 2025, 19:23 UTC

Ganancias

Oracle Weighs In on Cloud Margins. The Stock Is Rising. -- Barrons.com

16 oct 2025, 18:35 UTC

Charlas de Mercado
Ganancias

Charles Schwab Logs Another Quarter of Record Revenues, Earnings -- Market Talk

16 oct 2025, 18:31 UTC

Charlas de Mercado

Global Forex and Fixed Income Roundup: Market Talk

16 oct 2025, 18:31 UTC

Charlas de Mercado

Global Equities Roundup: Market Talk

16 oct 2025, 18:31 UTC

Charlas de Mercado

Charles Schwab Readies Spot Crypto Trading -- Market Talk

16 oct 2025, 16:57 UTC

Charlas de Mercado

Oil Futures Lose Ground as EIA Reports Crude Stock Build -- Market Talk

Comparación entre iguales

Cambio de precio

Assertio Holdings Inc Esperado

Precio Objetivo

By TipRanks

204.88% repunte

Estimación a 12 meses

Media 2.5 USD  204.88%

Máximo 3 USD

Mínimo 1 USD

De acuerdo con 4 analistas de Wall Street que ofrecen objetivos de precios a 12 meses para Assertio Holdings Inc Dist en los últimos 3 meses.

Consenso

By TipRanks

Compra Fuerte

4 ratings

3

Comprar

1

Mantener

0

Vender

Puntuación técnica

By Trading Central

0.618 / 0.649Soporte y Resistencia

Corto Plazo

Strong Bullish Evidence

Medio plazo

Bullish Evidence

Largo Plazo

Weak Bearish Evidence

Finanzas

Gastos de venta y administración

Gastos operativos

Beneficio antes de impuestos

Ventas

Coste de ventas

Beneficio bruto de ventas

Gasto por intereses de deuda

EBITDA

Beneficio operativo

$

Acerca de Assertio Holdings Inc

Assertio Holdings, Inc., a commercial pharmaceutical company, provides various products to patients in the United States. Its pharmaceutical products include INDOCIN, an oral and suppository solution for the treatment of moderate to severe rheumatoid arthritis, including acute flares of chronic disease; ankylosing spondylitis and osteoarthritis; and acute painful shoulder and gouty arthritis. It also provides Sympazan, a benzodiazepine for the adjunctive treatment of seizures related with lennox-gastaut syndrome in patients aged two years of age or older; CAMBIA, a non steroidal anti inflammatory drug (NSAID) for the treatment of migraine pain, nausea, photophobia, and phonophobia; Zipsor, a NSAID for relief of mild to moderate pain in adults; SPRIX, a NSAID for the short term management of moderate to moderately severe pain that requires analgesia at the opioid level; Otrexup, a single-dose auto-injector containing a prescription medicine and methotrexate that is used to treat patients with severe, active rheumatoid arthritis, and active polyarticular juvenile idiopathic arthritis, as well as treat adult with severe, recalcitrant, and disabling psoriasis; and ROLVEDON, a long-acting granulocyte colony-stimulating factor that is indicated to decrease the incidence of infection caused by febrile neutropenia. The company was formerly known as Assertio Therapeutics, Inc. and changed its name to Assertio Holdings, Inc. in May 2020. Assertio Holdings, Inc. was incorporated in 2020 and is headquartered in Lake Forest, Illinois.
help-icon Live chat